PHENYTOIN SODIUM
- Product NDC
- 71335-0232
- 11-digit product format
- 713350232
- Labeler code
- 71335
- Product ID
- 71335-0232_4e55a728-2703-47ae-a8d2-61247faecebe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PHENYTOIN SODIUM
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA040621
- Marketing category
- ANDA
- Marketing start
- 2006-12-12
- Marketing end
- 0000-00-00
- Substance
- PHENYTOIN SODIUM
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0232-1 | 71335023201 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-1) | 2013-07-30 | 0000-00-00 | No | No | Current |
| 71335-0232-2 | 71335023202 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-2) | 2013-07-30 | 0000-00-00 | No | No | Current |
| 71335-0232-3 | 71335023203 | 180 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-3) | 2013-07-30 | 0000-00-00 | No | No | Current |
| 71335-0232-4 | 71335023204 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-4) | 2013-07-30 | 0000-00-00 | No | No | Current |
| 71335-0232-5 | 71335023205 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-5) | 2013-07-30 | 0000-00-00 | No | No | Current |
| 71335-0232-6 | 71335023206 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-0232-6) | 2013-07-30 | 0000-00-00 | No | No | Current |